China Menopause Market Size & Outlook, 2022-2030
China menopause market, 2018-2030 (US$M)
Related Markets
China menopause market highlights
- The China menopause market generated a revenue of USD 2,502.2 million in 2022 and is expected to reach USD 3,695.4 million by 2030.
- The China market is expected to grow at a CAGR of 5% from 2023 to 2030.
- In terms of segment, dietary supplements was the largest revenue generating treatment in 2022.
- OTC pharma products is the most lucrative treatment segment registering the fastest growth during the forecast period.
Menopause market data book summary
| Market revenue in 2022 | USD 2,502.2 million |
| Market revenue in 2030 | USD 3,695.4 million |
| Growth rate | 5% (CAGR from 2022 to 2030) |
| Largest segment | Dietary supplements |
| Fastest growing segment | OTC pharma products |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | OTC pharma products, Dietary Supplements |
| Key market players worldwide | Bayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis |
Other key industry trends
- In terms of revenue, China accounted for 15.5% of the global menopause market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China menopause market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,632.2 million by 2030.
Dietary supplements was the largest segment with a revenue share of 98.49% in 2022. Horizon Databook has segmented the China menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
The country is witnessing key product innovations by key players, focused on using natural sources for obtaining dietary supplements. In February 2020, a biopharmaceutical company, the Zhilin Group, launched a dietary supplement obtained from extracted yam powder for use by menopausal women. Nativus Life Sciences Limited, a subsidiary of Zhilin Group, has made a regional distribution agreement with Wantian Tea Company Limited to promote the product to a wider customer pool.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Menopause Market Scope
Menopause Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China menopause market size, by treatment, 2018-2030 (US$M)
China Menopause Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
